The LEAD Coalition—along with 372 signatories—has submitted a letter responding to the CMS request for information on intensive lifestyle interventions (ILI) to slow progression of AD/ADRD. The letter outlines evidence and recommendations to assist in the development of a new CMS-supported ILI program to reduce AD/ADRD risk and protect brain health. The letter also encourages […]

Read the August 27th LEAD Coalition Newsletter below.

The LEAD Coalition, in partnership with the Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) has submitted an updated letter with Congress with 526 signatories in support of the bipartisan Alzheimer’s Screening and Prevention (ASAP) Act (H.R. 6130 / S.3267). This bipartisan legislation aims to ensure timely access to innovative Food and Drug Administration (FDA)-approved or […]

Read the July 29th LEAD Coalition Newsletter below.

Read the June 30th LEAD Coalition Newsletter below.

The LEAD Coalition, in partnership with UsAgainstAlzheimer’s, has released an urgent joint report – Shifting Ground: What Recent Changes to Health Programs Mean for Those Living with Alzheimer’s Disease – alerting people living with Alzheimer’s disease and related disorders, care partners, and their affected families that recent changes to Medicaid and other federal health programs could jeopardize […]

Read the May 27th LEAD Coalition Newsletter below.

The LEAD Coalition has responded to the five-year NIH strategic plan framework RFI (NOT-OD-26-047). The comments support advancing diverse and representative science, promoting mentorship and training support for early-career investigators, expanding research infrastructure to accelerate equitable real-world advances in AD/ADRD, along with other priorities. Read the comments here.

Read the April 29th LEAD Coalition Newsletter below.

The LEAD Coalition has submitted its FY2027 appropriations letter to Congress. The letter, signed by 475 LEAD Coalition member organizations and allies, urges Congress to reassert our country’s non-partisan national priority to overcome Alzheimer’s disease and related disorders (AD/ADRD) by making robust appropriations for federal agencies and ensuring complete and timely expenditure of those funds […]